semaglutide green bay UC San Diego researchers explore whether a GLP-1 drug can slow biological aging Introducing our newest medical weight

Wegovy is an injectable weight loss medication in the same family as Saxenda (a GLP-1 receptor agonist)

This timeline differs from Trulicitys more modest weight loss, highlighting another aspect of Mounjaro vs Trulicity effectiveness

NEJM 2023 Worth noting: The triglyceride drop (-30%) and liver fat improvement (-50%) were larger than weight loss alone would predict

Retatrutide (LY3437943) is an investigational, once-weekly injectable peptide developed by Eli Lilly

We are checking your browser for cookie support

You may be a good candidate for medical weight loss treatment through Klinic if you are an adult with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, high cholesterol, cardiovascular disease, or obstructive sleep apnea